Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The voltage-dependent calcium channel gamma-1 subunit is a regulatory protein that forms part of the L-type voltage-gated calcium channels, specifically in skeletal muscle. It is encoded by the CACNG1 gene. This subunit modulates the function of the channel complex, particularly influencing channel inactivation kinetics and contributing to excitation-contraction coupling in muscle tissue. Its expression appears to be exclusive or highly enriched in skeletal muscle cells. While no specific diseases are directly attributed solely to mutations or dysfunctions in CACNG1 at present, its critical role suggests that alterations could potentially impact muscular function or contribute to disorders involving excitation-contraction coupling.
Modulates the activity of L-type voltage-gated calcium channels, affecting calcium influx into cells.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-dependent calcium channel gamma-1 subunit (CACNG1).